Literature DB >> 7660369

The binding of Vibrio parahaemolyticus 125I-labeled thermostable directhemolysin to erythrocytes.

M Yoh1, N Morinaga, M Noda, T Honda.   

Abstract

Thermostable direct hemolysin (TDH) produced by Vibrio parahaemolyticus was iodinated using chloramine T. The 125I-labeled TDH retained up to 80% of the activity of intact toxin. The binding of 125I-TDH to rabbit erythrocytes was inhibited by addition of nonlabeled TDH. The binding of 125I-TDH to rabbit erythrocytes was completed in the 1st or 2nd min of incubation at 37 degrees C in contrast to that at 4 degrees C. 125I-TDH, which cannot lyse horse erythrocytes as does intact TDH, bound to horse erythrocytes as to those of rabbit. The dissociation constants (KD) derived Scatchard plots were 2.85, 4.39, 4.33 and 5.35 x 10-8M for rabbit, horse, human and sheep erythrocytes, respectively. The lytic sensitivity of various erythrocytes to TDH showed no relationship to the binding capacity.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7660369     DOI: 10.1016/0041-0101(95)00002-4

Source DB:  PubMed          Journal:  Toxicon        ISSN: 0041-0101            Impact factor:   3.033


  3 in total

Review 1.  Transanal hemorrhoidal dearterialization with mucopexy versus open hemorrhoidectomy in the treatment of hemorrhoids: a meta-analysis of randomized control trials.

Authors:  L Xu; H Chen; G Lin; Q Ge; H Qi; X He
Journal:  Tech Coloproctol       Date:  2016-11-25       Impact factor: 3.781

2.  Purification and characterization of a hemolysin produced by Vibrio mimicus.

Authors:  S Miyoshi; K Sasahara; S Akamatsu; M M Rahman; T Katsu; K Tomochika; S Shinoda
Journal:  Infect Immun       Date:  1997-05       Impact factor: 3.441

3.  Association of Vibrio parahaemolyticus thermostable direct hemolysin with lipid rafts is essential for cytotoxicity but not hemolytic activity.

Authors:  Shigeaki Matsuda; Toshio Kodama; Natsumi Okada; Kanna Okayama; Takeshi Honda; Tetsuya Iida
Journal:  Infect Immun       Date:  2009-11-23       Impact factor: 3.441

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.